Related Articles
Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era
Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study
Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP
Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab
Complete response to azacitidine priming and nab‑paclitaxel in non‑Hodgkin lymphoma resistant to biochemotherapy